RankingsPricing
  1. US-listed companies
  2. CONMED Corp
  3. Financials
  4. Cash from investing

CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-13-34.68%
Dec 31, 2023-20-91.97%
Dec 31, 2022-250+1578.52%
Dec 31, 2021-15+9.00%
Dec 31, 2020-14-96.48%
Dec 31, 2019-388+2248.47%
Dec 31, 2018-17-43.19%
Dec 31, 2017-29-89.08%
Dec 31, 2016-266+991.97%
Dec 31, 2015-24+17.83%
Dec 31, 2014-21+12.10%
Dec 31, 2013-18-82.59%
Dec 31, 2012-106+387.28%
Dec 31, 2011-22

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)